arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

DEXCOM INC

DXCM
$84.74 ▲ +1.75 (+2.11%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
87
Health
Excellent
Bullish
auto_awesome

Analytical Summary

DEXCOM INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $32.4B
Dividend Yield
Revenue Growth 13.1%
Op. Margin 24.3%
ROIC 9.5%
FCF / Share $0.48
Trailing P/E 130.4x
Price / Book 12.2x
FCF Yield 0.6%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.31B
↑ +13.1%
Net Income Profit after all expenses
$249.10M
↑ +38.5%
Operating Margin Operating profit as % of sales
24.3%
↑ +13.6% 74th
FCF / Share Free cash flow per share
$0.48
↓ -58.6%
Long-Term Debt Long-term obligations
$2.90M
↓ -17.1%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
80
Returns
93
Financial Health
94
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters